Showing 41-50 of 50 results for "".
- Amytrx Therapeutics Comes Out of the Gate Strong with Lead Program AMTX-100, Clinical Development Planshttps://practicaldermatology.com/news/amytrx-therapeutics-comes-out-of-the-gate-strong-with-lead-program-amtx-100-clinical-development-plans/2460531/Amytrx Therapeutics, Inc. is on the move. Founded in 2014, Nashville-based Amytrx is developing novel therapies for inflammatory diseases with lead program AMTX-100 currently in clinical development for dermatologic indications. AMTX-100 is a new anti-inflammatory therape
- Open Enrollment Underway for Phase 2b Trial of Topical AMTX-100 CF3 in ADhttps://practicaldermatology.com/news/open-enrollment-underway-for-phase-2b-trial-of-topical-amtx-100-cf3-in-ad/2461827/Amytrx Therapeutics is enrolling mild to moderate atopic dermatitis patients for its Phase 2b clinical trial of a topical formulation of AMTX-100 CF3. Eligible adults interested in participating or learning more about the trial are encouraged to visit the
- COVID-19, the Stock Market, and Dermatologyhttps://practicaldermatology.com/news/covid-19-the-stock-market-and-dermatology/2460688/By Amylee Martin, BS, Akshitha Thatiparthi, BS, Jeffrey Liu, BS, Jashin J. Wu, MD Novel coronavirus, COVID-19, is not only a major public health threat but has also impacted the economy. Due to the pandemic, experts predict a 0.5% decrease in t
- Amy McMichael, MDhttps://practicaldermatology.com/profiles/amy-mcmichael-md/LDGQpg/
- Amy Brodsky, MD, FAADhttps://practicaldermatology.com/profiles/amy-brodsky-md-faad/L6KQXq/
- Amy Lewis, MDhttps://practicaldermatology.com/profiles/amy-lewis-md/jG8EV9/
- Amy Forman Taub, MDhttps://practicaldermatology.com/profiles/amy-forman-taub-md/Lx5pm8/
- Amy Paller, MDhttps://practicaldermatology.com/profiles/amy-paller-md/Ld9Gl9/
- Amy Spizuoco, DO, FAOCDhttps://practicaldermatology.com/profiles/amy-spizuoco-do-faocd/j1NdAX/
- Amylee Martin, BShttps://practicaldermatology.com/profiles/amylee-martin-bs/Lgvgm4/
- Previous
- Next